Michael S. Simon

14.9k total citations · 2 hit papers
261 papers, 7.7k citations indexed

About

Michael S. Simon is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Michael S. Simon has authored 261 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Oncology, 74 papers in Cancer Research and 67 papers in Genetics. Recurrent topics in Michael S. Simon's work include Cancer Risks and Factors (78 papers), Global Cancer Incidence and Screening (64 papers) and BRCA gene mutations in cancer (35 papers). Michael S. Simon is often cited by papers focused on Cancer Risks and Factors (78 papers), Global Cancer Incidence and Screening (64 papers) and BRCA gene mutations in cancer (35 papers). Michael S. Simon collaborates with scholars based in United States, Norway and Germany. Michael S. Simon's co-authors include Kathleen E. Malone, Polly A. Marchbanks, Robert Spirtas, Giske Ursin, Leslie Bernstein, Ronald T. Burkman, Rowan T. Chlebowski, Jill A. McDonald, Suzanne G. Folger and Linda K. Weiss and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Michael S. Simon

253 papers receiving 7.4k citations

Hit Papers

Somatic mutations precede acute myeloid leukemia years be... 2018 2026 2020 2023 2018 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Simon United States 49 3.8k 2.0k 1.9k 1.6k 1.2k 261 7.7k
Patricia G. Moorman United States 41 4.8k 1.3× 2.0k 1.0× 3.3k 1.7× 1.1k 0.7× 1.7k 1.4× 135 8.7k
Andrea Micheli Italy 44 3.6k 1.0× 1.1k 0.6× 1.1k 0.6× 921 0.6× 1.2k 1.0× 124 7.1k
Kathryn J. Ruddy United States 44 4.1k 1.1× 1.3k 0.6× 1.6k 0.8× 1.7k 1.1× 1.4k 1.2× 324 8.7k
Carol Sweeney United States 45 3.3k 0.9× 1.1k 0.5× 1.3k 0.7× 1.1k 0.7× 2.0k 1.7× 138 6.9k
Joellen M. Schildkraut United States 51 1.7k 0.5× 2.2k 1.1× 1.2k 0.6× 946 0.6× 2.3k 1.9× 219 8.7k
Christobel Saunders Australia 43 3.0k 0.8× 1.2k 0.6× 1.6k 0.9× 987 0.6× 541 0.5× 318 7.1k
Giske Ursin United States 58 6.2k 1.6× 2.6k 1.3× 2.4k 1.3× 2.0k 1.3× 1.2k 1.0× 296 11.1k
David B. Thomas United States 50 2.4k 0.6× 1.4k 0.7× 1.0k 0.5× 1.2k 0.8× 1.8k 1.5× 222 9.1k
Isabel dos‐Santos‐Silva United Kingdom 47 4.1k 1.1× 948 0.5× 1.4k 0.8× 1.4k 0.9× 1.1k 0.9× 155 9.4k
Christopher A. Haiman United States 48 2.1k 0.6× 2.9k 1.5× 1.4k 0.8× 1.2k 0.8× 2.9k 2.4× 264 8.8k

Countries citing papers authored by Michael S. Simon

Since Specialization
Citations

This map shows the geographic impact of Michael S. Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Simon more than expected).

Fields of papers citing papers by Michael S. Simon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Simon. The network helps show where Michael S. Simon may publish in the future.

Co-authorship network of co-authors of Michael S. Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Simon. A scholar is included among the top collaborators of Michael S. Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Simon. Michael S. Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chlebowski, Rowan T., Aaron K. Aragaki, Kathy Pan, et al.. (2024). Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women’s Health Initiative. Cancer. 130(18). 3147–3156. 15 indexed citations
2.
Simon, Michael S., Candyce H. Kroenke, Jessica L. Krok‐Schoen, et al.. (2024). Social Support, Social Strain, Stressful Life Events and Mortality Among Postmenopausal Women With Breast Cancer. Psycho-Oncology. 33(11). e70013–e70013. 1 indexed citations
3.
Vasbinder, Alexi, et al.. (2024). Reply. JACC CardioOncology. 6(6). 988–989.
4.
Beebe‐Dimmer, Jennifer, Julie J. Ruterbusch, Michael S. Simon, et al.. (2023). The impact of high intensity interval training in a diverse group of cancer survivors: CAPABLE, a pilot study. Preventive Medicine Reports. 35. 102288–102288.
5.
Barac, Ana, Theodore M. Brasky, Aladdin H. Shadyab, et al.. (2023). Pre‐diagnosis lipid levels and mortality after obesity‐related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort. Cancer Medicine. 12(15). 16626–16636. 5 indexed citations
6.
Zhang, Zhenzhen, Fred K. Tabung, Qi Jin, et al.. (2022). Diet-Driven Inflammation and Insulinemia and Risk of Interval Breast Cancer. Nutrition and Cancer. 74(9). 3179–3193. 4 indexed citations
7.
Haring, Bernhard, Alexander P. Reiner, Jingmin Liu, et al.. (2021). Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative. Journal of the American Heart Association. 10(5). e018789–e018789. 60 indexed citations
8.
Trendowski, Matthew R., Christine M. Lusk, Julie J. Ruterbusch, et al.. (2021). Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes. Cancer Medicine. 10(22). 8151–8161. 21 indexed citations
9.
Kamgar, Mandana, Mark K. Greenwald, Theresa A. Hastert, et al.. (2021). Prevalence and predictors of peripheral neuropathy after breast cancer treatment. Cancer Medicine. 10(19). 6666–6676. 30 indexed citations
10.
Nagasaka, Misako, Amy Lehman, Rowan T. Chlebowski, et al.. (2020). COPD and lung cancer incidence in the Women’s Health Initiative Observational Study: A brief report. Lung Cancer. 141. 78–81. 9 indexed citations
11.
Beebe‐Dimmer, Jennifer, Julie J. Ruterbusch, Felicity W. K. Harper, et al.. (2020). Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study. Cancer. 126(9). 1987–1994. 36 indexed citations
12.
13.
Simon, Michael S., et al.. (2018). Lola V. Skadden and the Automation of the Legal Profession. 20(1). 234. 6 indexed citations
14.
Liang, Xiaoyun, Karen L. Margolis, Michael Hendryx, et al.. (2017). Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 26(2). 155–161. 17 indexed citations
15.
Beebe‐Dimmer, Jennifer, Cecilia Yee, Electra D. Paskett, et al.. (2017). Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women’s health initiative. BMC Cancer. 17(1). 848–848. 13 indexed citations
16.
Berstad, Paula, Ralph J. Coates, Leslie Bernstein, et al.. (2010). A Case-Control Study of Body Mass Index and Breast Cancer Risk in White and African-American Women. Cancer Epidemiology Biomarkers & Prevention. 19(6). 1532–1544. 86 indexed citations
17.
Simon, Michael S., et al.. (2010). Incidence of canine hip dysplasia: a survey of 272 cases.. Veterinary World. 3(5). 219–220. 3 indexed citations
18.
Simon, Michael S., et al.. (2009). Abstract B48: Racial differences in colorectal cancer survival in the Detroit metropolitan area. Cancer Epidemiology and Prevention Biomarkers. 18. 1 indexed citations
19.
Weiss, Linda K., Ronald T. Burkman, Kara L. Cushing‐Haugen, et al.. (2002). Hormone Replacement Therapy Regimens and Breast Cancer Risk. Obstetrics and Gynecology. 100(6). 1148–1158. 1 indexed citations
20.
Simon, Michael S., et al.. (2000). Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient?. PubMed. 6(10). 1102–13. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026